Keeping Drug Prices Down: Celgene Corp v Canada (Attorney General)
On January 20, 2011, the Supreme Court of Canada ("SCC") released its decision in Celgene Corp v Canada (Attorney General), 2011 SCC 1. In this case the SCC had to determine whether the Patented Medicine Prices Review Board (“Board”) correctly interpreted the Patent Act, RSC 1985, c P-4 [the Act]. Technically, this issue is one […]